175 related articles for article (PubMed ID: 33468714)
1. [Current Status and Prospects of the Comprehensive Cancer Genome Profiling].
Imoto I; Fukue M; Takaiso N
Gan To Kagaku Ryoho; 2021 Jan; 48(1):7-11. PubMed ID: 33468714
[TBL] [Abstract][Full Text] [Related]
2. Chronological improvement in precision oncology implementation in Japan.
Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
[TBL] [Abstract][Full Text] [Related]
3. Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy.
Yoshii Y; Okazaki S; Takeda M
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440540
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Reitsma M; Fox J; Borre PV; Cavanaugh M; Chudnovsky Y; Erlich RL; Gribbin TE; Anhorn R
J Manag Care Spec Pharm; 2019 May; 25(5):601-611. PubMed ID: 30632889
[TBL] [Abstract][Full Text] [Related]
5. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
[TBL] [Abstract][Full Text] [Related]
6. First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
Matsubara J; Mukai K; Kondo T; Yoshioka M; Kage H; Oda K; Kudo R; Ikeda S; Ebi H; Muro K; Hayashi R; Tokudome N; Yamamoto N; Muto M
JAMA Netw Open; 2023 Jul; 6(7):e2323336. PubMed ID: 37459099
[TBL] [Abstract][Full Text] [Related]
7. Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences.
Tóth E; Kürönya Z; Soós E; Pintér T; Butz H; Horváth Z; Csernák E; Grolmusz VK; Székely J; Straussz T; Lövey J; Jánvári L; Báthory-Fülöp L; Nagy P; Polgár C; Patócs A
Acta Oncol; 2024 Jun; 63():433-440. PubMed ID: 38881341
[TBL] [Abstract][Full Text] [Related]
8. Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies.
Matsuo M; Hashimoto K; Kogo R; Jiromaru R; Hongo T; Manako T; Nakagawa T
In Vivo; 2023; 37(5):2147-2154. PubMed ID: 37652518
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling for oncological advancements by precision medicine.
Pankiw M; Brezden-Masley C; Charames GS
Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
[TBL] [Abstract][Full Text] [Related]
10. Identification of barriers to implementation of precision oncology in patients with rare cancers.
Takamizawa S; Koyama T; Sunami K; Sudo K; Hirata M; Kubo T; Tao K; Cho H; Narita Y; Kato K; Yamazaki N; Ohe Y; Okusaka T; Matsui Y; Ogawa C; Yonemori K; Yamamoto N
Cancer Sci; 2024 Jun; 115(6):2023-2035. PubMed ID: 38538548
[TBL] [Abstract][Full Text] [Related]
11. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
Kanai M
Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
[TBL] [Abstract][Full Text] [Related]
12. Precision Oncology and the Universal Health Coverage System in Japan.
Ebi H; Bando H
JCO Precis Oncol; 2019; 3():. PubMed ID: 32923862
[TBL] [Abstract][Full Text] [Related]
13. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
Kage H; Shinozaki-Ushiku A; Ishigaki K; Sato Y; Tanabe M; Tanaka S; Tanikawa M; Watanabe K; Kato S; Akagi K; Uchino K; Mitani K; Takahashi S; Miura Y; Ikeda S; Kojima Y; Watanabe K; Mochizuki H; Yamaguchi H; Kawazoe Y; Kashiwabara K; Kohsaka S; Tatsuno K; Ushiku T; Ohe K; Yatomi Y; Seto Y; Aburatani H; Mano H; Miyagawa K; Oda K
Cancer Sci; 2023 Apr; 114(4):1710-1717. PubMed ID: 36601953
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.
Matsuoka A; Fujimori M; Koyama T; Sato A; Mori K; Hirata M; Tanabe N; Nakachi K; Kato S; Okamoto H; Ogawa K; Komatsu H; Iwasaku M; Miyaji T; Uchitomi Y
BMJ Open; 2023 Nov; 13(11):e072472. PubMed ID: 37996226
[TBL] [Abstract][Full Text] [Related]
16. Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer.
Signorovitch J; Zhou Z; Ryan J; Anhorn R; Chawla A
J Med Econ; 2019 Feb; 22(2):140-150. PubMed ID: 30430885
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer.
Tjota MY; Segal JP; Wang P
J Appl Lab Med; 2024 Jan; 9(1):76-91. PubMed ID: 38167763
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling in Predictive Testing of Cancer.
Svoboda M; Lohajova Behulova R; Slamka T; Sebest L; Repiska V
Physiol Res; 2023 Oct; 72(S3):S267-S275. PubMed ID: 37888970
[TBL] [Abstract][Full Text] [Related]
19. Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice.
Čerina D; Matković V; Katić K; Lovasić IB; Šeparović R; Canjko I; Jakšić B; Fröbe A; Pleština S; Bajić Ž; Vrdoljak E
Pathol Oncol Res; 2021; 27():1609963. PubMed ID: 34646088
[TBL] [Abstract][Full Text] [Related]
20. [Precision Medicine Provided by National Health Insurance].
Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]